{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:26:31Z","timestamp":1721694391569},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,22]]},"DOI":"10.7759\/cureus.65108","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T13:50:37Z","timestamp":1721656237000},"source":"Crossref","is-referenced-by-count":0,"title":["Correlation Between the Hepatitis C Virus NS3 Protein and CD30 Expression in Diffuse Large B-cell Lymphoma"],"prefix":"10.7759","author":[{"given":"Lili A","family":"Saputra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indrawati","family":"Indrawati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mardiah S","family":"Hardianti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nungki","family":"Anggorowati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3748%2Fwjg.v20.i32.11054","article-title":"Hepatitis C virus and diffuse large B-cell lymphoma: pathogenesis, behavior and treatment","volume":"20","author":"Visco C","year":"2014","unstructured":"Visco C, Finotto S. Hepatitis C virus and diffuse large B-cell lymphoma: pathogenesis, behavior and treatment. World J Gastroenterol. 2014, 20:11054-61. 10.3748%2Fwjg.v20.i32.11054","journal-title":"World J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9864.1000257","article-title":"Multicentre epidemiology and survival study of B cell non Hodgkin lymphoma patients in Indonesia","volume":"6","author":"Reksodiputro AH","year":"2015","unstructured":"Reksodiputro AH. Multicentre epidemiology and survival study of B cell non Hodgkin lymphoma patients in Indonesia. J Blood Disorders Transf. 2015, 6:257. 10.4172\/2155-9864.1000257","journal-title":"J Blood Disorders Transf"},{"key":"ref3","article-title":"Hepatitis-C infection incidence among the non-Hodgkin\u2019s B-cell lymphoma patients in the northeast of Iran","volume":"7","author":"Aledavood SA","year":"2014","unstructured":"Aledavood SA, Ghavam-Nasiri MR, Ghaffarzadegan K, et al.. Hepatitis-C infection incidence among the non-Hodgkin\u2019s B-cell lymphoma patients in the northeast of Iran. Iran J Cancer Prev. 2014, 7:147-51.","journal-title":"Iran J Cancer Prev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-020-00615-6","article-title":"HCV infection and non-Hodgkin lymphomas: an evolving story","volume":"20","author":"Defrancesco I","year":"2020","unstructured":"Defrancesco I, Zerbi C, Rattotti S, Merli M, Bruno R, Paulli M, Arcaini L. HCV infection and non-Hodgkin lymphomas: an evolving story. Clin Exp Med. 2020, 20:321-8. 10.1007\/s10238-020-00615-6","journal-title":"Clin Exp Med"},{"key":"ref5","article-title":"Prevalence and clinicopathologic features of CD30-positive de novo diffuse large B-cell lymphoma in Chinese patients: a retrospective study of 232 cases","volume":"8","author":"Gong QX","year":"2015","unstructured":"Gong QX, Lu TX, Liu C, et al.. Prevalence and clinicopathologic features of CD30-positive de novo diffuse large B-cell lymphoma in Chinese patients: a retrospective study of 232 cases. Int J Clin Exp Pathol. 2015, 8:15825-35.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.574761","article-title":"CD30: an important new target in hematologic malignancies","volume":"52","author":"Deutsch YE","year":"2011","unstructured":"Deutsch YE, Tadmor T, Podack ER, Rosenblatt JD. CD30: an important new target in hematologic malignancies. Leuk Lymphoma. 2011, 52:1641-54. 10.3109\/10428194.2011.574761","journal-title":"Leuk Lymphoma"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001368","article-title":"Practical approaches on CD30 detection and reporting in lymphoma diagnosis","volume":"44","author":"Xu ML","year":"2020","unstructured":"Xu ML, Gabali A, Hsi ED, et al.. Practical approaches on CD30 detection and reporting in lymphoma diagnosis. Am J Surg Pathol. 2020, 44:e1-14. 10.1097\/PAS.0000000000001368","journal-title":"Am J Surg Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156384","article-title":"In situ hepatitis C NS3 protein detection is associated with high grade features in hepatitis C-associated B-cell non-Hodgkin lymphomas","volume":"11","author":"Canioni D","year":"2016","unstructured":"Canioni D, Michot JM, Rabiega P, et al.. In situ hepatitis C NS3 protein detection is associated with high grade features in hepatitis C-associated B-cell non-Hodgkin lymphomas. PLoS One. 2016, 11:e0156384. 10.1371\/journal.pone.0156384","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23138","article-title":"Hepatitis C virus infection is an independent prognostic factor in follicular lymphoma","volume":"9","author":"Shimono J","year":"2018","unstructured":"Shimono J, Miyoshi H, Kato T, et al.. Hepatitis C virus infection is an independent prognostic factor in follicular lymphoma. Oncotarget. 2018, 9:1717-25. 10.18632\/oncotarget.23138","journal-title":"Oncotarget"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-021-01387-5","article-title":"CD30 expression in oral and oropharyngeal diffuse large B cell lymphoma, not otherwise specified","volume":"16","author":"Morais-Perdig\u00e3o AL","year":"2022","unstructured":"Morais-Perdig\u00e3o AL, Rodrigues-Fernandes CI, Ara\u00fajo GR, et al.. CD30 expression in oral and oropharyngeal diffuse large B cell lymphoma, not otherwise specified. Head Neck Pathol. 2022, 16:476-85. 10.1007\/s12105-021-01387-5","journal-title":"Head Neck Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18585\/inabj.v13i1.1421","article-title":"Association of AID and MUM1 by immunohistochemistry in diffuse large B-cell lymphoma","volume":"13","author":"Hardianti M","year":"2021","unstructured":"Hardianti M, Setiawan S, Anggorowati N, Probowati W. Association of AID and MUM1 by immunohistochemistry in diffuse large B-cell lymphoma. Indones Biomed J. 2021, 13:10.18585\/inabj.v13i1.1421","journal-title":"Indones Biomed J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2015.1026455","article-title":"Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma - a Swedish population-based study","volume":"54","author":"Hedstr\u00f6m G","year":"2015","unstructured":"Hedstr\u00f6m G, Peterson S, Berglund M, Jerkeman M, Enblad G. Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma - a Swedish population-based study. Acta Oncol. 2015, 54:924-32. 10.3109\/0284186X.2015.1026455","journal-title":"Acta Oncol"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.3889\/oamjms.2020.4645","article-title":"CD30 expression in germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma","volume":"8","author":"Julianty PF","year":"2020","unstructured":"Julianty PF, Ham MF, Kusmardi K, Harahap AS. CD30 expression in germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma. Open Access Maced J Med Sci. 2020, 8:375-80.","journal-title":"Open Access Maced J Med Sci"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.31557\/apjcb.2020.5.3.107-113","article-title":"CD30 expression and its correlation with clinicopathologic features in Indonesian diffuse large B-cell lymphoma","volume":"5","author":"Reynelda Santoso M","year":"2020","unstructured":"Reynelda Santoso M, Suci Hardianti M, Indrawati I, Anggorowati N. CD30 expression and its correlation with clinicopathologic features in Indonesian diffuse large B-cell lymphoma. Asian Pac J Cancer Biol. 2020, 5:107-13.","journal-title":"Asian Pac J Cancer Biol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jop.13208","article-title":"Prognostic significance of CD30 expression in diffuse large B-cell lymphoma: a systematic review with meta-analysis","volume":"50","author":"Rodrigues-Fernandes CI","year":"2021","unstructured":"Rodrigues-Fernandes CI, Abreu LG, Radhakrishnan R, et al.. Prognostic significance of CD30 expression in diffuse large B-cell lymphoma: a systematic review with meta-analysis. J Oral Pathol Med. 2021, 50:587-93. 10.1111\/jop.13208","journal-title":"J Oral Pathol Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12680","article-title":"CD30 expression and its correlation with MYC rearrangement in de novo diffuse large B-cell lymphoma","volume":"97","author":"Wang XJ","year":"2016","unstructured":"Wang XJ, Seegmiller AC, Reddy NM, Li S. CD30 expression and its correlation with MYC rearrangement in de novo diffuse large B-cell lymphoma. Eur J Haematol. 2016, 97:39-47. 10.1111\/ejh.12680","journal-title":"Eur J Haematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/110.1.32","article-title":"Immunohistochemical detection of hepatitis C antigen by monoclonal antibody TORDJI-22 compared with PCR viral detection","volume":"110","author":"Brody RI","year":"1998","unstructured":"Brody RI, Eng S, Melamed J, et al.. Immunohistochemical detection of hepatitis C antigen by monoclonal antibody TORDJI-22 compared with PCR viral detection. Am J Clin Pathol. 1998, 110:32-7. 10.1093\/ajcp\/110.1.32","journal-title":"Am J Clin Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/2040620715623924","article-title":"Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?","volume":"7","author":"Vannata B","year":"2016","unstructured":"Vannata B, Arcaini L, Zucca E. Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?. Ther Adv Hematol. 2016, 7:94-107. 10.1177\/2040620715623924","journal-title":"Ther Adv Hematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000083055","article-title":"Clinical features and outcome in HCV-positive aggressive non-Hodgkin's lymphoma","volume":"44","author":"Tomita N","year":"2003","unstructured":"Tomita N, Kodama F, Takabayashi M, et al.. Clinical features and outcome in HCV-positive aggressive non-Hodgkin's lymphoma. Leuk Lymphoma. 2003, 44:1159-64. 10.1080\/1042819031000083055","journal-title":"Leuk Lymphoma"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.5016","article-title":"Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs","volume":"24","author":"Besson C","year":"2006","unstructured":"Besson C, Canioni D, Lepage E, et al.. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs. J Clin Oncol. 2006, 24:953-60. 10.1200\/JCO.2005.01.5016","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl131","article-title":"Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy","volume":"17","author":"Visco C","year":"2006","unstructured":"Visco C, Arcaini L, Brusamolino E, et al.. Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy. Ann Oncol. 2006, 17:1434-40. 10.1093\/annonc\/mdl131","journal-title":"Ann Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701732861","article-title":"Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphoma","volume":"49","author":"Park BB","year":"2008","unstructured":"Park BB, Kim JS, Lee YY, et al.. Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphoma. Leuk Lymphoma. 2008, 49:88-94. 10.1080\/10428190701732861","journal-title":"Leuk Lymphoma"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.094318","article-title":"Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi","volume":"99","author":"Merli M","year":"2014","unstructured":"Merli M, Visco C, Spina M, et al.. Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi. Haematologica. 2014, 99:489-96. 10.3324\/haematol.2013.094318","journal-title":"Haematologica"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23889","article-title":"Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 Lympho-C study","volume":"90","author":"Michot JM","year":"2015","unstructured":"Michot JM, Canioni D, Driss H, et al.. Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 Lympho-C study. Am J Hematol. 2015, 90:197-203. 10.1002\/ajh.23889","journal-title":"Am J Hematol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1999.0653","article-title":"Soluble CD30 serum level in HCV-positive chronic active hepatitis: a surrogate marker of disease activity?","volume":"12","author":"Foschi FG","year":"2000","unstructured":"Foschi FG, Gramenzi A, Castelli E, et al.. Soluble CD30 serum level in HCV-positive chronic active hepatitis: a surrogate marker of disease activity?. Cytokine. 2000, 12:815-8. 10.1006\/cyto.1999.0653","journal-title":"Cytokine"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80409-6","article-title":"Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection","volume":"26","author":"Reiser M","year":"1997","unstructured":"Reiser M, Marousis CG, Nelson DR, et al.. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J Hepatol. 1997, 26:471-8. 10.1016\/S0168-8278(97)80409-6","journal-title":"J Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/217943-correlation-between-the-hepatitis-c-virus-ns3-protein-and-cd30-expression-in-diffuse-large-b-cell-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T13:50:51Z","timestamp":1721656251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/217943-correlation-between-the-hepatitis-c-virus-ns3-protein-and-cd30-expression-in-diffuse-large-b-cell-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.65108","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,22]]}}}